- Home
- EDTK vs BFRI Comparison
EDTK vs BFRI Comparison
Compare EDTK & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDTK | BFRI |
|---|---|---|
| Founded | 2013 | 1997 |
| Country | China | United States |
| Employees | N/A | 94 |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 15.0M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | EDTK | BFRI |
|---|---|---|
| Price | $0.91 | $1.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 1.8K | ★ 393.6K |
| Earning Date | 01-16-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | N/A | $16.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.80 | $0.57 |
| 52 Week High | $1.18 | $1.27 |
Technical Indicators
Market Signals| Indicator | EDTK | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 37.89 | 61.55 |
| Support Level | $0.89 | $0.71 |
| Resistance Level | $1.03 | N/A |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 4.76 | 74.55 |
Price Performance
Historical ComparisonAbout EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.